Atlas Trials

Effect of the CFTR-modulating Triple Therapy Elexacaftor - Tezacaftor - Ivacaftor

Clinical trial NCT05576324 · UNKNOWN

Trial details

NCT number
NCT05576324
Sponsor
University of Erlangen-Nürnberg Medical School
Status
UNKNOWN
Study type
OBSERVATIONAL
Cystic Fibrosis
Start date
2020-12-30
Primary completion
2023-10-18
Enrollment
130

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.